Abstract
Hepatocytes derived from human embryonic stem cells (ESCs) are a potential cell source for regenerative medicine. However, the successful differentiation of human ESCs into mature hepatocytes has been difficult to achieve because the definitive mechanisms governing hepatocyte differentiation have not yet been well defined. The CD45−CD49f±Thy1+gp38+ mesenchymal cells that reside in murine fetal livers induce hepatic progenitor cells to differentiate into mature hepatocytes by direct cell-cell contact. A cell line named MLSgt20 was also successively established from these mesenchymal cells. These MLSgt20 cells possess the ability to promote the hepatic maturation of not only murine ESCs, but also human ESC-derived endodermal cells. To promote this maturation, human ESCs are treated with a two-step procedure for hepatic maturation; first, human ESCs are differentiated into endodermal cells, then human ESC-derived endodermal cells are matured into functional hepatocytes by co-culture with the MLSgt20 cells, thereby forming cell aggregates. These human ESC-derived hepatocyte-like cells possess hepatic functions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.